Vermillion, Inc.

Vermillion, Inc. (VRML) is a pharmaceutical company that discovers, develops and commercializes diagnostic tests to improve patient care by physicians. It offers diagnostic products with focus on clinical conditions like oncology, cardiology and hematology. VRML develops and offers diagnostic tests such as thrombotic thrombocytopenic purpura (TTP) test, peripheral artery disease (PAD) blood test, and ovarian tumor triage test, ovarian cancer high-risk triage test, ovarian cancer prognosis test for thrombotic thrombocytopenic purpura (TTP), peripheral artery disease (PAD), and ovarian cancer. The company has collaborations with various pharmaceutical companies and research institutions such as University of Texas M. D. Anderson Cancer Center, John Hopkins School of Medicine, Stanford University, University of Kentucky, Rigshospitalet, and Ohio State University Research Foundation. It operates through its subsidiaries in Switzerland, Denmark, the UK, Japan, China and Germany. VRML is headquartered in Texas, the US.

Street: 
47350 Fremont Blvd.
City: 
Fremont
Postcode: 
94538
Federal State : 
United States
WebSite: 
www.vermillion.com
Fax: 
1-510-2262801

Company Index Score

Current Index Score Historical Index Score
  • Vermillion, Inc. currently scores 50 % in the index.
  • Vermillion, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Vermillion, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets